B/L Trademark

Trademark Overview

On Wednesday, September 3, 2025, a trademark application was filed for B/L with the United States Patent and Trademark Office. The USPTO has given the B/L trademark a serial number of 99373113. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, May 4, 2026. This trademark is owned by Gilead Sciences Ireland UC. The B/L trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of viral infection, HIV infection, and autoimmune diseases and disorders
b/l

General Information

Serial Number99373113
Word MarkB/L
Filing DateWednesday, September 3, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, May 4, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral infection, HIV infection, and autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Wednesday, September 3, 2025NEW APPLICATION ENTERED
Wednesday, September 3, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 23, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, January 25, 2026ASSIGNED TO EXAMINER
Friday, January 30, 2026NON-FINAL ACTION WRITTEN
Friday, January 30, 2026NON-FINAL ACTION E-MAILED
Friday, January 30, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 14, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 14, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 4, 2026SUSPENSION LETTER WRITTEN
Monday, May 4, 2026LETTER OF SUSPENSION E-MAILED
Monday, May 4, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

infection autoimmune disorders diseases viral preparations treatment pharmaceutical